An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.

Chung, Wai-Shan; Chen, Shin-Cheh; Ko, Tai-Ming; Lin, Yung-Chang; Lin, Sheng-Hsuan; Lo, Yung-Feng; Tseng, Shu-Chi; Yu, Chi-Chang

Chung, Wai-Shan; Chen, Shin-Cheh; Ko, Tai-Ming; Lin, Yung-Chang; Lin, Sheng-Hsuan; Lo, Yung-Feng; Tseng, Shu-Chi; Yu, Chi-Chang.

Afiliação

Chung WS; Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.
Chen SC; College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Ko TM; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Lin YC; Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.
Lin SH; College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Lo YF; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Tseng SC; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Yu CC; College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Cancers (Basel) ; 14(17)2022 Aug 28.

Article em En | MEDLINE | ID: mdl-36077706

Palavras-chave

neoadjuvant chemotherapy; treatment response prediction; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article